Claims
- 1. A quinone derivative represented by the formula: ##STR242## wherein X and Y may be the same or different from each other and each represents a hydroxyl group or a group represented by the formula --(--OCH.sub.2 --).sub.n --OR.sup.6, where n is 0 or 1 and R.sup.6 is a lower alkyl group or an acyl group; R.sup.1 is an alkyl group having 2 to 20 carbon atoms; a cycloalkyl group; a cycloalkylalkyl group; an alkenyl group; an alkynyl group; an arylalkyl group; a group represented by the formula --(--CH.sub.2 --).sub.p --CN where p is an integer from 1 to 10; an alkyl-substituted heteroaryl group, a group represented by the formula --(--CH.sub.2 --).sub.q --B where q is an integer from 1 to 6 and B is a group of the formula ##STR243## where r is 0, 1 or 2 and R.sup.7 is a lower alkyl group, a cycloalkyl group or an aryl group, a group represented by the formula --O--R.sup.11 where R.sup.11 is a lower alkyl group or an aryl group, or a group represented by the formula --(--CH.sub.2 --CH.sub.2 --O--).sub.s --CH.sub.3 where s is an integer from 1 to 3; R.sup.2 is a group represented by --OR.sup.8 where R.sup.8 is a hydrogen atom, a lower alkyl group, or a group represented by the formula ##STR244## where R.sup.9 and R.sup.10 is the same or different from each other and each is a hydrogen atom, a lower alkyl group, a hydroxyalkyl group or a heteroaryl group, or R.sup.9 and R.sup.10 form a heterocyclic group with the adjacent nitrogen atom, said heterocyclic group optionally being substituted; and R.sup.3, R.sup.4 and R.sup.5 are the same or different from each other and each is a hydrogen atom, a lower alkyl group or a lower alkoxy group or a pharmacologically acceptable salt thereof.
- 2. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is an alkyl group having 2 to 20 carbon atoms and R.sup.2 is a group represented by the formula --OR.sup.8 wherein R.sup.8 is a hydrogen atom or a lower alkyl group, or a group represented by the formula: ##STR245## wherein R.sup.9 and R.sup.10 may be the same or different from each other and each is a hydrogen atom, a lower alkyl group, a hydroxyalkyl group or a heteroaryl group, or R.sup.9 and R.sup.10 form a ring together with the nitrogen atom bonded thereto, which may further contain a nitrogen atom and/or an oxygen atom and may be substituted.
- 3. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 2, wherein R.sup.2 is a hydroxyl group.
- 4. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is an alkyl group having 2 to 12 carbon atoms and R.sup.2 is a hydroxyl group.
- 5. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is an alkyl group having 7 to 12 carbon atoms and R.sup.2 is a hydroxyl group.
- 6. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is a nonyl group.
- 7. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is a nonyl group and R.sup.2 is a hydroxyl group.
- 8. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is a 3-methylbutyl group.
- 9. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.1 is a cycloalkyl group.
- 10. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein the cycloalkylalkyl group is a cyclohexylmethyl group.
- 11. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3, R.sup.4 and R.sup.5 are each independently a lower alkyl group or a lower alkoxy group.
- 12. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 and R.sup.4 are each a lower alkoxy group and R.sup.5 is a lower alkyl group.
- 13. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 and R.sup.4 are each a methoxy group and R.sup.5 is a methyl group.
- 14. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 and R.sup.4 are each a methoxy group, R.sup.5 is a methyl group, R.sup.1 is a nonyl group and R.sup.2 is a hydroxyl group.
- 15. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3, R.sup.4 and R.sup.5 are each a methoxy group, R.sup.2 is a hydroxyl group and R.sup.1 is a 3-methylbutyl group.
- 16. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 is a methoxy group, R.sup.4 is an ethoxy group, R.sup.5 is a methyl group, R.sup.1 is a 3-methylbutyl group and R.sup.2 is a hydroxyl group.
- 17. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 is a methoxy group, R.sup.4 is an ethoxy group, R.sup.5 is a methyl group, R.sup.1 is a cyclohexylmethyl group and R.sup.2 is a hydroxyl group.
- 18. A quinone derivative or a pharmacologically acceptable salt thereof according to claim 1, wherein R.sup.3 and R.sup.4 are each a methoxy group, R.sup.5 is a methyl group, R.sup.1 is a nonyl group and R.sup.2 is a hydroxyl group.
- 19. A pharmacological composition which comprises a pharmacologically effective amount of the quinone derivative or a salt thereof as defined in claim 1 and a pharmacologically acceptable carrier.
Priority Claims (1)
Number |
Date |
Country |
Kind |
1-232761 |
Sep 1989 |
JPX |
|
Parent Case Info
This is a division of Ser. No. 7/576 054, filed Aug. 31, 1990 now U.S. Pat. No. 5,210,239.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5169856 |
Goto et al. |
Dec 1992 |
|
5286750 |
Mueller et al. |
Feb 1994 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
576054 |
Aug 1990 |
|